Home / Businesswire / Joint venture to bring EverSweet™ sweeteners to market faster is finalized

Joint venture to bring EverSweet™ sweeteners to market faster is finalized

REINACH, Switzerland–(BUSINESS WIRE)–Evolva (SIX: EVE), the company pioneering the rapid
development, scale-up, and commercialization of sustainably sourced,
next-generation ingredients, congratulates Cargill and DSM on finalizing
their new joint venture, Avansya™. Avansya™ will produce
fermentation-based sweeteners and market them under one brand name,

Evolva's existing royalty contract with Cargill is unchanged and remains
in force on all EverSweet™ products sold.

"This joint venture is positive news for Evolva shareholders because it
has the potential to expand and accelerate global market adoption of
EverSweet™ sweeteners," said Evolva CEO Oliver Walker.

"The world's food and beverage producers need the kind of
non-artificial, zero-calorie, great-tasting sweetener options that
EverSweet™ sweeteners can supply,” said Cargill Vice President Food
Segment North America, Chris Simons. “This joint venture allows us to
advance the EverSweet™ product line even faster to address that global
food and beverage sweetener paradigm shift.”

– ends –

About Evolva

Evolva solves the supply chain issues of nature through a 21st century
mix of biotechnology and fermentation. We develop, make and sell
ingredients that provide significant health, wellness and nutrition
benefits to people in their daily life, but whose supply chain issues
have limited their use until now. Our flagship ingredients are stevia,
nootkatone and resveratrol. To make our world sustainable requires
nature and technology to work together as one, and our aim is to play a
(small) part in achieving this transformation. For more information see www.evolva.com.

This press release contains specific forward-looking statements,
e.g. statements including terms like believe, assume, expect or similar
expressions. Such forward-looking statements are subject to known and
unknown risks, uncertainties and other factors which may result in a
substantial divergence between the actual results, financial situation,
development or performance of the company and those explicitly or
implicitly presumed in these statements. Against the background of these
uncertainties readers should not place undue reliance on forward-looking
statements. The company assumes no responsibility to update
forward-looking statements or to adapt them to future events or


Oliver Walker, CEO
[email protected]
41 61 485 2034

Paul Verbraeken, IR
[email protected]
41 61 485 2035

Stephan Herrera, USA
[email protected]
1 415 794 4005